Acino Completes Takeda Deal In Emerging Markets
Covers UAE, Egypt, Saudi Arabia, Ukraine And South Africa
Acino has completed its acquisition of parts of Takeda’s primary care portfolio in selected countries in the Middle East, Africa and Ukraine.
You may also be interested in...
Partnership will combine AbCellera’s screening of antibodies to the virus with Lilly’s development, commercial capabilities. Vir adds Biogen tie-up to its ongoing coronavirus efforts.
After registering itself as a legal entity in Turkey, Acino is set to begin commercial operations in the country this year.
India’s Shilpa Medicare has received a warning letter from the US FDA for its finished dosage formulation facility in Jadcherla, Telangana. The company has insisted that supplies from the facility will not be disrupted while it engages with the FDA to resolve the issues.